D.A. Davidson & Co’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$21.1K Hold
10,000
﹤0.01% 1429
2025
Q1
$12.2K Sell
10,000
-9,000
-47% -$11K ﹤0.01% 1392
2024
Q4
$24.5K Sell
19,000
-11,771
-38% -$15.2K ﹤0.01% 1400
2024
Q3
$84.6K Sell
30,771
-18,000
-37% -$49.5K ﹤0.01% 1347
2024
Q2
$110K Buy
48,771
+1,116
+2% +$2.52K ﹤0.01% 1320
2024
Q1
$114K Buy
47,655
+5,000
+12% +$12K ﹤0.01% 1338
2023
Q4
$70.8K Buy
42,655
+4,830
+13% +$8.02K ﹤0.01% 1334
2023
Q3
$72.6K Buy
37,825
+5,000
+15% +$9.6K ﹤0.01% 1289
2023
Q2
$47.3K Hold
32,825
﹤0.01% 1313
2023
Q1
$68.9K Buy
32,825
+15
+0% +$32 ﹤0.01% 1308
2022
Q4
$37.1K Hold
32,810
﹤0.01% 1285
2022
Q3
$53K Sell
32,810
-12,525
-28% -$20.2K ﹤0.01% 1250
2022
Q2
$59K Sell
45,335
-9,975
-18% -$13K ﹤0.01% 1244
2022
Q1
$89K Hold
55,310
﹤0.01% 1260
2021
Q4
$114K Sell
55,310
-2,000
-3% -$4.12K ﹤0.01% 1234
2021
Q3
$222K Sell
57,310
-4,000
-7% -$15.5K ﹤0.01% 1118
2021
Q2
$196K Sell
61,310
-4,000
-6% -$12.8K ﹤0.01% 1134
2021
Q1
$142K Sell
65,310
-702,011
-91% -$1.53M ﹤0.01% 1108
2020
Q4
$1.72M Sell
767,321
-86,395
-10% -$194K 0.03% 375
2020
Q3
$2.28M Buy
853,716
+2,615
+0.3% +$6.98K 0.04% 292
2020
Q2
$2.6M Buy
851,101
+12,836
+2% +$39.3K 0.05% 259
2020
Q1
$1.64M Sell
838,265
-2,683
-0.3% -$5.26K 0.03% 356
2019
Q4
$2.41M Buy
840,948
+20,790
+3% +$59.5K 0.04% 329
2019
Q3
$3.01M Buy
820,158
+29,284
+4% +$107K 0.05% 269
2019
Q2
$3.28M Buy
790,874
+36,519
+5% +$152K 0.06% 239
2019
Q1
$3.86M Buy
754,355
+35,432
+5% +$181K 0.07% 231
2018
Q4
$2.47M Buy
718,923
+29,645
+4% +$102K 0.05% 290
2018
Q3
$4.14M Buy
689,278
+32,751
+5% +$197K 0.07% 220
2018
Q2
$4.18M Sell
656,527
-74,773
-10% -$475K 0.08% 207
2018
Q1
$3.47M Buy
731,300
+43,147
+6% +$204K 0.07% 226
2017
Q4
$2.3M Sell
688,153
-2,807
-0.4% -$9.37K 0.05% 296
2017
Q3
$1.48M Sell
690,960
-47,540
-6% -$102K 0.03% 422
2017
Q2
$1.82M Sell
738,500
-62,090
-8% -$153K 0.04% 330
2017
Q1
$1.84M Buy
800,590
+76,167
+11% +$175K 0.04% 314
2016
Q4
$709K Buy
724,423
+121,692
+20% +$119K 0.02% 559
2016
Q3
$681K Buy
602,731
+33,382
+6% +$37.7K 0.02% 550
2016
Q2
$836K Buy
569,349
+148,539
+35% +$218K 0.02% 431
2016
Q1
$601K Buy
420,810
+49,909
+13% +$71.3K 0.02% 486
2015
Q4
$608K Buy
370,901
+58,015
+19% +$95.1K 0.02% 490
2015
Q3
$732K Buy
312,886
+171,305
+121% +$401K 0.03% 446
2015
Q2
$386K Buy
141,581
+11,081
+8% +$30.2K 0.01% 646
2015
Q1
$437K Buy
130,500
+10,000
+8% +$33.5K 0.01% 611
2014
Q4
$418K Buy
120,500
+900
+0.8% +$3.12K 0.01% 633
2014
Q3
$601K Sell
119,600
-74,558
-38% -$375K 0.02% 534
2014
Q2
$2.68M Buy
194,158
+43,515
+29% +$601K 0.09% 227
2014
Q1
$2.31M Sell
150,643
-42,307
-22% -$648K 0.08% 243
2013
Q4
$1.56M Buy
+192,950
New +$1.56M 0.06% 291